Login to Your Account



ISTA Slides After FDA Issues 'Approvable' Letter On Vitrase

By Kim Coghill


Tuesday, April 8, 2003
Although it's unclear at this point, the FDA may require a confirmatory study for ISTA Pharmaceuticals Inc.'s Vitrase, a single injection to the eye for vitreous hemorrhage. (BioWorld Today)

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription